{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:17:40Z","timestamp":1790248660680,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.4065\/80.7.947","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:26:10Z","timestamp":1232760370000},"page":"947-958","source":"Crossref","is-referenced-by-count":94,"title":["The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis"],"prefix":"10.4065","volume":"80","author":[{"given":"Ayalew","family":"Tefferi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gary","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/80.7.947_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","article-title":"The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: proposals by the French-American-British Cooperative Leukaemia Group","volume":"87","author":"Bennett","year":"1994","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib3","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0609.2003.00086.x","article-title":"Chronic basophilic leukemia: a distinict clinico-pathologic entity?","volume":"71","author":"Pardanani","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.4065\/80.7.947_bib5","unstructured":"Tefferi A, Gilliland DG. Classification of myeloproliferative disorders: from Dameshek towards a semi-molecular system. Best Pract Res Clin Haematol. In press."},{"key":"10.4065\/80.7.947_bib6","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1073\/pnas.88.15.6848","article-title":"Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction","volume":"88","author":"Gilliland","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib7","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1073\/pnas.58.4.1468","article-title":"Clonal origin of chronic myelocytic leukemia in man","volume":"58","author":"Fialkow","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM197308092890608","article-title":"Clonal origin of chronic myelocytic leukemia","volume":"289","author":"Barr","year":"1973","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem-cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","article-title":"Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage","volume":"63","author":"Fialkow","year":"1977","journal-title":"Am J Med"},{"key":"10.4065\/80.7.947_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI109193","article-title":"Chronic myelocytic leukemia: origin of some lymphocytes from leukemic stem cells","volume":"62","author":"Fialkow","year":"1978","journal-title":"J Clin Invest"},{"key":"10.4065\/80.7.947_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/287049a0","article-title":"Involvement of the B-lymphoid system in chronic myelogenous leukaemia","volume":"287","author":"Martin","year":"1980","journal-title":"Nature"},{"key":"10.4065\/80.7.947_bib14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib15","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","article-title":"Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia","volume":"101","author":"Reeder","year":"2003","journal-title":"Blood"},{"issue":"suppl 1","key":"10.4065\/80.7.947_bib16","first-page":"S7","article-title":"Molecular genetics of human leukemia","volume":"12","author":"Gilliland","year":"1998","journal-title":"Leukemia"},{"key":"10.4065\/80.7.947_bib17","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/80.7.947_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.4065\/80.7.947_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","article-title":"Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22","volume":"36","author":"Groffen","year":"1984","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/315758a0","article-title":"Structural organization of the bcr gene and its role in the Ph\u2032 translocation","volume":"315","author":"Heisterkamp","year":"1985","journal-title":"Nature"},{"key":"10.4065\/80.7.947_bib21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.4065\/80.7.947_bib22","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1073\/pnas.87.17.6649","article-title":"Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR\/ABL [published correction appears in Proc Natl Acad Sci U S A. 1990;87:9072]","volume":"87","author":"Kelliher","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.4065\/80.7.947_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(91)90148-R","article-title":"BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner","volume":"66","author":"Pendergast","year":"1991","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib25","first-page":"839","article-title":"The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\/ABL and p210BCR\/ABL to the phosphatidylinositol-3\u2032 kinase pathway","volume":"12","author":"Sattler","year":"1996","journal-title":"Oncogene"},{"key":"10.4065\/80.7.947_bib26","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1073\/pnas.84.18.6558","article-title":"In vitro transformation of immature hematopoietic cells by the P210 BCR\/ABL oncogene product of the Philadelphia chromosome","volume":"84","author":"McLaughlin","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib27","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood.V86.12.4603.bloodjournal86124603","article-title":"BCR\/ABL P210 and P190 cause distinct leukemia in transgenic mice","volume":"86","author":"Voncken","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib29","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.4065\/80.7.947_bib31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"Buttner","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.4065\/80.7.947_bib32","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0145-2126(02)00303-X","article-title":"Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease","volume":"27","author":"Pardanani","year":"2003","journal-title":"Leuk Res"},{"key":"10.4065\/80.7.947_bib34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib36","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1182\/blood.V91.12.4419","article-title":"Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor \u03b2 receptor (PDGF\u03b2R) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)","volume":"91","author":"Ross","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib37","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1182\/blood.V98.8.2518","article-title":"Rabaptin-5 is a novel fusion partner to platelet-derived growth factor \u03b2 receptor in chronic myelomonocytic leukemia","volume":"98","author":"Magnusson","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib38","first-page":"3592","article-title":"Fusion of H4\/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)","volume":"60","author":"Kulkarni","year":"2000","journal-title":"Cancer Res"},{"key":"10.4065\/80.7.947_bib39","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1182\/blood.V97.12.3910","article-title":"H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor \u03b2 gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)","volume":"97","author":"Schwaller","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib40","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2003-04-1150","article-title":"Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib","volume":"102","author":"Wilkinson","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib41","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1182\/blood.V90.11.4271","article-title":"Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution","volume":"90","author":"Abe","year":"1997","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000046641","article-title":"Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor beta","volume":"107","author":"Steer","year":"2002","journal-title":"Acta Haematol"},{"key":"10.4065\/80.7.947_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2141.2003.04051.x","article-title":"Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders","volume":"120","author":"Baxter","year":"2003","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000046640","article-title":"Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach: a case report","volume":"107","author":"Granjo","year":"2002","journal-title":"Acta Haematol"},{"key":"10.4065\/80.7.947_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa020150","article-title":"Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta","volume":"347","author":"Apperley","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2141.2002.03469.x","article-title":"Receptor tyrosine kinase mutations in myeloid neoplasms","volume":"117","author":"Gupta","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib47","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1158\/0008-5472.CAN-04-2005","article-title":"p53-Binding protein 1 is fused to the platelet-derived growth factor receptor \u03b2 in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder","volume":"64","author":"Grand","year":"2004","journal-title":"Cancer Res"},{"key":"10.4065\/80.7.947_bib48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/gcc.1195","article-title":"Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL","volume":"32","author":"Fioretos","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.7.947_bib49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2002-02-0577","article-title":"Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3)","volume":"101","author":"Guasch","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gcc.1177","article-title":"Identification of four new translocations involving FGFR1 in myeloid disorders","volume":"32","author":"Sohal","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.7.947_bib51","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood.V90.8.3136","article-title":"Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11","volume":"90","author":"Still","year":"1997","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng0198-84","article-title":"FGFR1 is fused with a novel zincfinger gene, ZNF198, in the t(8;13) leukaemia\/lymphoma syndrome","volume":"18","author":"Xiao","year":"1998","journal-title":"Nat Genet"},{"key":"10.4065\/80.7.947_bib53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<70::AID-GCC9>3.0.CO;2-5","article-title":"Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder","volume":"21","author":"Smedley","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.7.947_bib54","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.onc.1201601","article-title":"t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12","volume":"16","author":"Chaffanet","year":"1998","journal-title":"Oncogene"},{"key":"10.4065\/80.7.947_bib55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/hmg\/7.4.637","article-title":"The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP","volume":"7","author":"Smedley","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.4065\/80.7.947_bib56","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1073\/pnas.95.10.5712","article-title":"Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)","volume":"95","author":"Popovici","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/80.7.947_bib57","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood.V92.5.1735","article-title":"Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome","volume":"92","author":"Reiter","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/geno.1998.5634","article-title":"The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome","volume":"55","author":"Kulkarni","year":"1999","journal-title":"Genomics"},{"key":"10.4065\/80.7.947_bib59","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V99.10.3857","article-title":"NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15) [published correction appears in Blood. 2002;100:1132]","volume":"99","author":"Rosati","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.V86.2.834.bloodjournal862834","article-title":"Myeloproliferative disorder associated with 8p11 translocations [letter]","volume":"86","author":"Aguiar","year":"1995","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.1996.00386.x","article-title":"Chronic myelomonocytic leukaemia with t(8;9)(p11;q34) in childhood: an example of the 8p11 myeloproliferative disorder?","volume":"92","author":"Nakayama","year":"1996","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib62","first-page":"1252","article-title":"A young child with acquired t(8;9)(p11;q34): additional proof that 8p11 is involved in mixed myeloid\/T lymphoid malignancies [letter]","volume":"10","author":"van den Berg","year":"1996","journal-title":"Leukemia"},{"key":"10.4065\/80.7.947_bib63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/gcc.20144","article-title":"8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes","volume":"42","author":"Belloni","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.7.947_bib64","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V93.4.1381","article-title":"The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1","volume":"93","author":"Popovici","year":"1999","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib65","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.thj.6200561","article-title":"Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases","volume":"5","author":"Vizmanos","year":"2004","journal-title":"Hematol J"},{"key":"10.4065\/80.7.947_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/gcc.20023","article-title":"Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome","volume":"40","author":"Grand","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.7.947_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"key":"10.4065\/80.7.947_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","article-title":"Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1","volume":"92","author":"Side","year":"1998","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","article-title":"Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia","volume":"12","author":"Largaespada","year":"1996","journal-title":"Nat Genet"},{"key":"10.4065\/80.7.947_bib70","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1203\/01.PDR.0000113462.98851.2E","article-title":"Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia","volume":"55","author":"Gitler","year":"2004","journal-title":"Pediatr Res"},{"key":"10.4065\/80.7.947_bib72","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.4065\/80.7.947_bib73","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.4065\/80.7.947_bib74","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib75","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.4065\/80.7.947_bib76","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.4065\/80.7.947_bib77","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and the myelodysplastic syndrome","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib78","author":"Jones"},{"key":"10.4065\/80.7.947_bib79","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1095920","article-title":"Protein kinase inhibitors: insights into drug design from structure","volume":"303","author":"Noble","year":"2004","journal-title":"Science"},{"key":"10.4065\/80.7.947_bib80","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0968-0004(94)90134-1","article-title":"The coordinated action of protein tyrosine phosphatases and kinases in cell signaling","volume":"19","author":"Sun","year":"1994","journal-title":"Trends Biochem Sci"},{"key":"10.4065\/80.7.947_bib81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.4065\/80.7.947_bib82","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib83","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","article-title":"The protein tyrosine kinase family of the human genome","volume":"19","author":"Robinson","year":"2000","journal-title":"Oncogene"},{"key":"10.4065\/80.7.947_bib84","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene"},{"key":"10.4065\/80.7.947_bib85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The Janus kinases (Jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol"},{"key":"10.4065\/80.7.947_bib86","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbrc.2004.09.171","article-title":"Src protein-tyrosine kinase structure and regulation","volume":"324","author":"Roskoski","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4065\/80.7.947_bib87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-230X(02)85003-5","article-title":"The Abl family kinases: mechanisms of regulation and signaling","volume":"85","author":"Pendergast","year":"2002","journal-title":"Adv Cancer Res"},{"key":"10.4065\/80.7.947_bib88","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/sj.onc.1205398","article-title":"JAKs, STATs and Src kinases in hematopoiesis","volume":"21","author":"Rane","year":"2002","journal-title":"Oncogene"},{"key":"10.4065\/80.7.947_bib89","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/sj.onc.1203878","article-title":"Regulation of cell death by the Abl tyrosine kinase","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.4065\/80.7.947_bib90","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s000180050392","article-title":"The Janus kinase family of protein tyrosine kinases and their role in signaling","volume":"55","author":"Yeh","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.4065\/80.7.947_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(03)00411-3","article-title":"Of JAKs, STATs, blind watchmakers, jeeps and trains","volume":"546","author":"Kerr","year":"2003","journal-title":"FEBS Lett"},{"key":"10.4065\/80.7.947_bib92","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc799","article-title":"Oncogenic tyrosine kinases and the DNA-damage response","volume":"2","author":"Skorski","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.4065\/80.7.947_bib93","first-page":"61","article-title":"Signaling via JAK tyrosine kinases: growth hormone receptor as a model system","volume":"53","author":"Carter-Su","year":"1998","journal-title":"Recent Prog Horm Res"},{"key":"10.4065\/80.7.947_bib94","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","article-title":"Signal transducer and activator of transcription proteins in leukemias","volume":"101","author":"Benekli","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib95","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.4065\/80.7.947_bib96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N","article-title":"Negative regulation of the JAK\/STAT pathway","volume":"21","author":"Starr","year":"1999","journal-title":"Bioessays"},{"key":"10.4065\/80.7.947_bib97","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.4065\/80.7.947_bib98","doi-asserted-by":"crossref","first-page":"29338","DOI":"10.1074\/jbc.M003456200","article-title":"CIS3\/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2","volume":"275","author":"Sasaki","year":"2000","journal-title":"J Biol Chem"},{"key":"10.4065\/80.7.947_bib99","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/me.14.9.1338","article-title":"Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B","volume":"14","author":"Stofega","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.4065\/80.7.947_bib100","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/gene.20063","article-title":"Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice","volume":"40","author":"Krempler","year":"2004","journal-title":"Genesis"},{"key":"10.4065\/80.7.947_bib103","doi-asserted-by":"crossref","first-page":"12350","DOI":"10.1074\/jbc.272.19.12350","article-title":"The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells","volume":"272","author":"Sakai","year":"1997","journal-title":"J Biol Chem"},{"key":"10.4065\/80.7.947_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.4065\/80.7.947_bib105","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib106","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.4065\/80.7.947_bib107","doi-asserted-by":"crossref","first-page":"32704","DOI":"10.1074\/jbc.M103100200","article-title":"TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3\u2032-kinase\/protein kinase B signaling pathway","volume":"276","author":"Nguyen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.4065\/80.7.947_bib108","first-page":"1438","article-title":"TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein\/Jun kinase (SAPK\/JNK), and p38 signaling pathways","volume":"100","author":"Ho","year":"2002","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib109","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1097-2765(00)00067-8","article-title":"Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL\/JAK2","volume":"6","author":"Schwaller","year":"2000","journal-title":"Mol Cell"},{"key":"10.4065\/80.7.947_bib110","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","article-title":"The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2","volume":"65","author":"Reiter","year":"2005","journal-title":"Cancer Res"},{"key":"10.4065\/80.7.947_bib111","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/j.1460-2075.1995.tb07127.x","article-title":"An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects","volume":"14","author":"Luo","year":"1995","journal-title":"EMBO J"},{"key":"10.4065\/80.7.947_bib112","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Bone-marrow responses in polycythemia vera [letter]","volume":"290","author":"Prchal","year":"1974","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib113","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood.V49.3.399.399","article-title":"Polycythemia vera: hormonal modulation of erythropoiesis in vitro","volume":"49","author":"Golde","year":"1977","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib114","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI108706","article-title":"Erythroid colony formation by polycythemia vera bone marrow in vitro: dependence on erythropoietin","volume":"59","author":"Zanjani","year":"1977","journal-title":"J Clin Invest"},{"key":"10.4065\/80.7.947_bib115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.exphem.2003.11.003","article-title":"Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera","volume":"32","author":"Ugo","year":"2004","journal-title":"Exp Hematol"},{"key":"10.4065\/80.7.947_bib116","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-472X(98)00003-4","article-title":"A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation","volume":"27","author":"Arcasoy","year":"1999","journal-title":"Exp Hematol"},{"key":"10.4065\/80.7.947_bib117","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(95)90351-8","article-title":"Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals","volume":"80","author":"Klingmuller","year":"1995","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib118","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0167-7799(97)01060-3","article-title":"Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency","volume":"15","author":"Shultz","year":"1997","journal-title":"Trends Biotechnol"},{"key":"10.4065\/80.7.947_bib119","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.1988.tb02395.x","article-title":"Megakaryocytic colony formation in polycythaemia vera and secondary erythrocytosis","volume":"69","author":"Juvonen","year":"1988","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1987.tb01293.x","article-title":"Colony formation by megakaryocytic progenitors in essential thrombocythaemia","volume":"66","author":"Juvonen","year":"1987","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib121","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0609.1989.tb01219.x","article-title":"Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders","volume":"42","author":"Battegay","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.4065\/80.7.947_bib122","first-page":"271","article-title":"Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia","volume":"9","author":"Florensa","year":"1995","journal-title":"Leukemia"},{"key":"10.4065\/80.7.947_bib123","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","article-title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","volume":"96","author":"Axelrad","year":"2000","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib124","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI115009","article-title":"Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3","volume":"87","author":"Dai","year":"1991","journal-title":"J Clin Invest"},{"key":"10.4065\/80.7.947_bib125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1993.tb04688.x","article-title":"Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3","volume":"83","author":"Kobayashi","year":"1993","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib127","first-page":"311","article-title":"In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors: studies on primary and secondary polycythemia","volume":"79","author":"Montagna","year":"1994","journal-title":"Haematologica"},{"key":"10.4065\/80.7.947_bib128","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V80.4.891.891","article-title":"Polycythemia vera, II: hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor","volume":"80","author":"Dai","year":"1992","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.1994.tb03246.x","article-title":"Polycythaemia vera, III: burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression","volume":"86","author":"Dai","year":"1994","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"10.4065\/80.7.947_bib130","first-page":"94a","article-title":"Hypersensitivity of polycythemia vera megakaryocytic progenitors to thrombopoietin [abstract]","volume":"88","author":"Martin","year":"1996","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0303-7207(01)00489-0","article-title":"Alterations of the insulin-like growth factor system in patients with polycythemia vera","volume":"181","author":"Michl","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.4065\/80.7.947_bib132","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0301-472X(01)00637-3","article-title":"STAT3 is constitutively active in some patients with Polycythemia rubra vera","volume":"29","author":"R\u00f6der","year":"2001","journal-title":"Exp Hematol"},{"key":"10.4065\/80.7.947_bib133","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood.V97.11.3424","article-title":"Increased expression of the INK4a\/ARF locus in polycythemia vera","volume":"97","author":"Dai","year":"2001","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib134","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/me.16.4.774","article-title":"PRL activates the cyclin D1 promoter via the Jak2\/Stat pathway","volume":"16","author":"Brockman","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.4065\/80.7.947_bib135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM199802263380902","article-title":"Expression of Bcl-x in erythroid precursors from patients with polycythemia vera","volume":"338","author":"Silva","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a-\/-5b-\/- mice: a direct role for Stat5 in Bcl-X(L) induction","volume":"98","author":"Socolovsky","year":"1999","journal-title":"Cell"},{"key":"10.4065\/80.7.947_bib137","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.4065\/80.7.947_bib138","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-10-4093","article-title":"Lnk inhibits erythropoiesis and Epodependent JAK2 activation and downstream signaling pathways","author":"Tong","year":"2005","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib139","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1172\/JCI111840","article-title":"Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia","volume":"75","author":"Raskind","year":"1985","journal-title":"J Clin Invest"},{"key":"10.4065\/80.7.947_bib140","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI110546","article-title":"In vitro studies of human pluripotential hematopoietic progenitors in polycythemia vera: direct evidence of stem cell involvement","volume":"69","author":"Ash","year":"1982","journal-title":"J Clin Invest"},{"key":"10.4065\/80.7.947_bib141","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"10.4065\/80.7.947_bib142","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ajh.2830120414","article-title":"Mixed myeloid-lymphoid colonies in a patient with polycythemia vera","volume":"12","author":"Beckman","year":"1982","journal-title":"Am J Hematol"},{"key":"10.4065\/80.7.947_bib143","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00273630","article-title":"Gd(-) Abrami: a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis","volume":"30","author":"Kahn","year":"1975","journal-title":"Humangenetik"},{"key":"10.4065\/80.7.947_bib144","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.1994.tb04723.x","article-title":"Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement","volume":"86","author":"Tsukamoto","year":"1994","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2141.2001.02796.x","article-title":"Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia","volume":"113","author":"Tefferi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib146","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2141.2002.03763.x","article-title":"Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected","volume":"119","author":"Najfeld","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000064754","article-title":"Cytogenetic and molecular genetic aspects of essential thrombocythemia","volume":"108","author":"Steensma","year":"2002","journal-title":"Acta Haematol"},{"key":"10.4065\/80.7.947_bib148","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2141.2001.03131.x","article-title":"Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia","volume":"115","author":"Tefferi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib149","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cancergencyto.2003.09.011","article-title":"Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?","volume":"151","author":"Zamora","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/80.7.947_bib150","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2402980","article-title":"Molecular cytogenetics of polycythaemia vera: lack of occult rearrangements detectable by 20q LSP screening, CGH, and M-FISH [letter]","volume":"17","author":"Gribble","year":"2003","journal-title":"Leukemia"},{"key":"10.4065\/80.7.947_bib151","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X","article-title":"Gain of 9p in the pathogenesis of polycythemia vera","volume":"22","author":"Chen","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.4065\/80.7.947_bib152","first-page":"464","article-title":"Polycythemia vera: analysis of DNA from blood granulocytes using comparative genomic hybridization","volume":"86","author":"Westwood","year":"2001","journal-title":"Haematologica"},{"key":"10.4065\/80.7.947_bib153","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-03-0744","article-title":"Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib154","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/protein\/14.1.27","article-title":"Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation","volume":"14","author":"Lindauer","year":"2001","journal-title":"Protein Eng"},{"key":"10.4065\/80.7.947_bib155","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1128\/MCB.20.10.3387-3395.2000","article-title":"Regulation of the Jak2 tyrosine kinase by its pseudokinase domain","volume":"20","author":"Saharinen","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.4065\/80.7.947_bib156","doi-asserted-by":"crossref","first-page":"47954","DOI":"10.1074\/jbc.M205156200","article-title":"The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction","volume":"277","author":"Saharinen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.4065\/80.7.947_bib157","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1128\/MCB.24.11.4968-4978.2004","article-title":"Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling","volume":"24","author":"Feener","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.4065\/80.7.947_bib158","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/jm049470k","article-title":"Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation","volume":"48","author":"Sandberg","year":"2005","journal-title":"J Med Chem"},{"key":"10.4065\/80.7.947_bib159","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/BC.2004.045","article-title":"The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity","volume":"385","author":"van den Akker","year":"2004","journal-title":"Biol Chem"},{"key":"10.4065\/80.7.947_bib160","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1365-2141.2000.02127.x","article-title":"JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells","volume":"109","author":"De Vos","year":"2000","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib161","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","year":"2001"},{"key":"10.4065\/80.7.947_bib162","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4065\/78.2.174","article-title":"Polycythemia vera: a comprehensive review and clinical recommendations","volume":"78","author":"Tefferi","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/80.7.947_bib163","series-title":"Platelets","first-page":"667","article-title":"Thrombocytosis and essential thrombocythemia","author":"Tefferi","year":"2002"},{"key":"10.4065\/80.7.947_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.21105","article-title":"Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility","author":"Sirhan","year":"2005","journal-title":"Cancer"},{"key":"10.4065\/80.7.947_bib165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1600-0609.2005.00424.x","article-title":"Management of patients with polycythaemia vera: results of a survey among Swedish haematologists","volume":"74","author":"Andreasson","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.4065\/80.7.947_bib166","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2141.2002.03386.x","article-title":"Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia","volume":"117","author":"Messinezy","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4065\/80.7.947_bib167","first-page":"1194","article-title":"Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis","volume":"89","author":"Mossuz","year":"2004","journal-title":"Haematologica"},{"issue":"1, suppl 2","key":"10.4065\/80.7.947_bib168","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/shem.2001.23040","article-title":"Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders","volume":"38","author":"Prchal","year":"2001","journal-title":"Semin Hematol"},{"key":"10.4065\/80.7.947_bib169","first-page":"317","article-title":"Diagnostic impact of bone marrow histopathology in polycythemia vera (PV)","volume":"20","author":"Thiele","year":"2005","journal-title":"Histol Histopathol"},{"key":"10.4065\/80.7.947_bib170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1078\/0344-0338-5710013","article-title":"Polycythemia rubra vera versus secondary polycythemias: a clinico-pathological evaluation of distinctive features in 199 patients","volume":"197","author":"Thiele","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.4065\/80.7.947_bib171","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0025-6196(12)61011-8","article-title":"Chromosome studies in 104 patients with polycythemia vera","volume":"66","author":"Diez-Martin","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/80.7.947_bib172","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/sj.thj.6200123","article-title":"Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia","volume":"2","author":"Dobo","year":"2001","journal-title":"Hematol J"},{"key":"10.4065\/80.7.947_bib173","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/80.7.947_bib174","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","article-title":"Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib175","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2003-03-0919","article-title":"Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis","volume":"102","author":"Klippel","year":"2003","journal-title":"Blood"},{"key":"10.4065\/80.7.947_bib176","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2141.2004.05149.x","article-title":"Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay","volume":"127","author":"Koch","year":"2004","journal-title":"Br J Haematol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611615723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611615723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T01:16:50Z","timestamp":1589505410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611615723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":176,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0025619611615723"],"URL":"https:\/\/doi.org\/10.4065\/80.7.947","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}